Salmonella typhi Vi polysaccharide - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
VIVAXIM 1mL injection syringe composite pack AUST R: 82745Active ingredients:
Hepatitis a virus antigen
Salmonella typhi Vi polysaccharide
Dosage form: Injection, suspension
Sponsor: Sanofi-Aventis Australia Pty Ltd
Phone: 1800818806
|
Deletion from market:
01 Apr 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Manufacturing
|